Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT

Health Technology Assessment : HTA
Anthony P MorrisonDavid Kingdon

Abstract

Clozapine (clozaril, Mylan Products Ltd) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication. However, a significant number of patients who trial clozapine have an inadequate response and experience persistent symptoms, called clozapine-resistant schizophrenia (CRS). There is little evidence regarding the clinical effectiveness of pharmacological or psychological interventions for this population. To evaluate the clinical effectiveness and cost-effectiveness of cognitive-behavioural therapy (CBT) for people with CRS and to identify factors predicting outcome. The Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial was a parallel-group, randomised, outcome-blinded evaluation trial. Randomisation was undertaken using permuted blocks of random size via a web-based platform. Data were analysed on an intention-to-treat (ITT) basis, using random-effects regression adjusted for site, age, sex and baseline symptoms. Cost-effectiveness analyses were carried out to determine whether or not CBT was associated with a greater number of quality-adjusted life-years (QALYs) and higher costs than treatment as usual (TAU). Secondary care mental health services in five citi...Continue Reading

References

Mar 1, 1992·Schizophrenia Research·D AddingtonJ Joyce
Mar 1, 1992·The Australian and New Zealand Journal of Psychiatry·P D McGorry
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Nov 1, 1986·The Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology·A BaddeleyH Spinnler
Jul 1, 1982·Archives of General Psychiatry·N C Andreasen
Jan 1, 1982·Addictive Behaviors·H A Skinner
Oct 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·A V Mackay
Feb 18, 1995·BMJ : British Medical Journal·R J Cook, D L Sackett
Aug 1, 1994·The American Journal of Psychiatry·D P BernsteinJ Ruggiero
Feb 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·P Chadwick, M Birchwood
Nov 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·V DruryF Macmillan
Feb 1, 1997·Archives of General Psychiatry·J M GoldD R Weinberger
Nov 28, 1997·The British Journal of Psychiatry : the Journal of Mental Science·E KuipersC Hadley
Feb 17, 1998·The British Journal of Psychiatry : the Journal of Mental Science·P GaretyS Jones
Sep 11, 1998·The British Journal of Medical Psychology·G HaddockE B Faragher
Nov 7, 1998·BMJ : British Medical Journal·D G Altman
Jul 14, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·A PintoL DeSimone
Sep 9, 2000·Schizophrenia Research·J van OsA Ravelli
Mar 10, 2001·Psychological Medicine·P A GaretyP E Bebbington
Nov 13, 2001·Clinical Psychology Review·L C Johns, J van Os
Aug 17, 2002·The International Journal of Social Psychiatry·Kausar Suhail, Raymond Cochrane
Oct 25, 2002·The British Journal of Clinical Psychology·Anthony P MorrisonSarah Nothard
Nov 20, 2002·The British Journal of Clinical Psychology·Daniel FreemanPaul E Bebbington
Dec 26, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Elliot M GoldnerJulian M Somers
Dec 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Norbert MüllerAndreas Straube
Jan 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·I JanssenJ van Os
Apr 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Robert C DurhamRanald R Macdonald
Sep 27, 2003·The Australian and New Zealand Journal of Psychiatry·Retta AndresenPeter Caputi
Oct 24, 2003·Psychiatry Research·Jennifer Boyd RitsherMonica Grajales
Nov 5, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Gillian HaddockShôn Lewis
Jan 2, 2004·The American Journal of Psychiatry·Michael J MinzenbergSophia Vinogradov
Feb 19, 2004·Epidemiologia e psichiatria sociale·Jim van Os
Jun 23, 2004·Journal of Clinical Psychopharmacology·John M Davis, Nancy Chen
Jul 24, 2004·BMJ : British Medical Journal·Michael D Rawlins, Anthony J Culyer
Oct 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Louise C JohnsHoward Meltzer
Dec 1, 2004·Statistics in Medicine·Ian R White, Simon G Thompson
Apr 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Lucia R ValmaggiaCees J Slooff
May 3, 2005·The American Journal of Psychiatry·Susan R McGurkJohn M Kane
Jun 29, 2005·Schizophrenia Research·Stefan LeuchtRolf R Engel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2022 Meta ULC. All rights reserved